Fibromyalgia |
|
|
| Use speech to control your computer at twice the speed of keyboard and mouse: see Utter Command | See Utter Command in action: see Video |
Clinical Trial: An Open-Label Trial of Pregabalin in Patients with Fibromyalgia
This study is currently recruiting patients.
Verified by Pfizer September 2005
|
Purpose
| Condition | Intervention | Phase |
|---|---|---|
| Fibromyalgia | Drug: Pregabalin | Phase III |
MedlinePlus related topics: Fibromyalgia
Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety Study
Official Title: A Long-Term, Open-Label, Safety Trial of Pregabalin in Patients with Fibromyalgia
Expected Total Enrollment: 428
Study start: January 2005
Eligibility
Inclusion Criteria:
- Patients must have met the inclusion criteria for the preceding fibromyalgia Protocol A0081056
- Must have received pregabalin/placebo under double-blind conditions.
Exclusion Criteria:
- Patients may not participate in the study if they experienced a serious adverse event during the previous fibromyalgia Study A0081056 which was determined to be related to the study medication by the investigator or the sponsor.
Location and Contact Information
Alabama
Pfizer Investigational Site, Huntsville, Alabama, 35801, United States; Recruiting
Pfizer Investigational Site, Birmingham, Alabama, 35294, United States; No longer recruiting
Arizona
Pfizer Investigational Site, Phoenix, Arizona, 85032, United States; Recruiting
Pfizer Investigational Site, Scottsdale, Arizona, 85254, United States; Recruiting
Pfizer Investigational Site, Phoenix, Arizona, 85023, United States; Recruiting
Arkansas
Pfizer Investigational Site, Hot Springs, Arkansas, 71913, United States; Recruiting
Pfizer Investigational Site, Little Rock, Arkansas, 72205-7101, United States; Recruiting
California
Pfizer Investigational Site, Whittier, California, 90601, United States; Recruiting
Pfizer Investigational Site, Walnut Creek, California, 94598, United States; Recruiting
Pfizer Investigational Site, Redondo Beach, California, 90277, United States; Recruiting
Pfizer Investigational Site, Newport Beach, California, 92660, United States; Recruiting
Pfizer Investigational Site, Riverside, California, 92506, United States; Recruiting
Pfizer Investigational Site, Los Alamitos, California, 90720, United States; Recruiting
Pfizer Investigational Site, Northridge, California, 91324-4625, United States; Recruiting
Pfizer Investigational Site, Pismo Beach, California, 93449, United States; Recruiting
Pfizer Investigational Site, Beverly Hills, California, 90211, United States; Recruiting
Connecticut
Pfizer Investigational Site, Danbury, Connecticut, 06810, United States; Recruiting
Pfizer Investigational Site, New Milford, Connecticut, 06776, United States; Recruiting
Pfizer Investigational Site, Stratford, Connecticut, 06615, United States; Recruiting
Florida
Pfizer Investigational Site, Miami, Florida, 33173, United States; Recruiting
Pfizer Investigational Site, Palm Beach Gardens, Florida, 33410, United States; Recruiting
Pfizer Investigational Site, Clearwater, Florida, 33761, United States; Recruiting
Pfizer Investigational Site, Plantation, Florida, 33324, United States; Recruiting
Pfizer Investigational Site, Sunrise, Florida, 33351-6637, United States; Recruiting
Pfizer Investigational Site, Ocala, Florida, 34474, United States; Recruiting
Pfizer Investigational Site, St. Petersburg, Florida, 33709, United States; Recruiting
Pfizer Investigational Site, St. Petersburg, Florida, 33703, United States; Recruiting
Pfizer Investigational Site, West Palm Beach, Florida, 33409, United States; Recruiting
Georgia
Pfizer Investigational Site, Atlanta, Georgia, 30328, United States; Recruiting
Pfizer Investigational Site, Decatur, Georgia, 30033, United States; No longer recruiting
Idaho
Pfizer Investigational Site, Boise, Idaho, 83704, United States; Recruiting
Illinois
Pfizer Investigational Site, Oak Brook, Illinois, 60523, United States; Recruiting
Pfizer Investigational Site, Chicago, Illinois, 60610, United States; No longer recruiting
Pfizer Investigational Site, Peoria, Illinois, 61614, United States; Recruiting
Pfizer Investigational Site, Maywood, Illinois, 60153, United States; No longer recruiting
Kansas
Pfizer Investigational Site, Overland Park, Kansas, 66215, United States; No longer recruiting
Pfizer Investigational Site, Kansas City, Kansas, 66160, United States; Recruiting
Kentucky
Pfizer Investigational Site, Madisonville, Kentucky, 42431, United States; Recruiting
Louisiana
Pfizer Investigational Site, New Orleans, Louisiana, 70114, United States; Recruiting
Maryland
Pfizer Investigational Site, Baltimore, Maryland, 21215, United States; No longer recruiting
Massachusetts
Pfizer Investigational Site, Newton, Massachusetts, 02462, United States; No longer recruiting
Michigan
Pfizer Investigational Site, Kalamazoo, Michigan, 49009, United States; Recruiting
Pfizer Investigational Site, Lansing, Michigan, 48917, United States; Recruiting
Missouri
Pfizer Investigational Site, Kansas City, Missouri, 64114, United States; Recruiting
New Hampshire
Pfizer Investigational Site, Lebanon, New Hampshire, 03766, United States; Recruiting
New Jersey
Pfizer Investigational Site, Princeton, New Jersey, 08540, United States; Recruiting
New York
Pfizer Investigational Site, Rochester, New York, 14618, United States; Recruiting
Pfizer Investigational Site, Albany, New York, 12205, United States; Recruiting
Pfizer Investigational Site, New York, New York, 10003, United States; Recruiting
North Carolina
Pfizer Investigational Site, Charlotte, North Carolina, 28210, United States; Recruiting
Pfizer Investigational Site, Winston Salem, North Carolina, 27103, United States; Recruiting
Pfizer Investigational Site, Winston Salem, North Carolina, 27103, United States; Recruiting
Pfizer Investigational Site, Wilmington, North Carolina, 28401, United States; Recruiting
Pfizer Investigational Site, Wilmington, North Carolina, 28403, United States; Recruiting
Ohio
Pfizer Investigational Site, Toledo, Ohio, 43623, United States; Recruiting
Pfizer Investigational Site, Mogadore, Ohio, 44260, United States; Recruiting
Pfizer Investigational Site, Cincinnati, Ohio, 45267-0559, United States; Recruiting
Pfizer Investigational Site, Columbus, Ohio, 43124, United States; No longer recruiting
Pfizer Investigational Site, Columbus, Ohio, 43212, United States; Recruiting
Oklahoma
Pfizer Investigational Site, Oklahoma City, Oklahoma, 73109, United States; No longer recruiting
Oregon
Pfizer Investigational Site, Medford, Oregon, 97504, United States; Recruiting
Pfizer Investigational Site, Eugene, Oregon, 97401, United States; Recruiting
Pfizer Investigational Site, Portland, Oregon, 97201, United States; Recruiting
Pfizer Investigational Site, Portland, Oregon, 97239, United States; Recruiting
Pennsylvania
Pfizer Investigational Site, West Reading, Pennsylvania, 19611-1124, United States; Recruiting
Pfizer Investigational Site, Pottstown, Pennsylvania, 19464, United States; Recruiting
Pfizer Investigational Site, Wyomissing, Pennsylvania, 19610, United States; Recruiting
Pfizer Investigational Site, Duncansville, Pennsylvania, 16635, United States; Recruiting
Pfizer Investigational Site, Johnstown, Pennsylvania, 15904, United States; Recruiting
Pfizer Investigational Site, Pittsburgh, Pennsylvania, 15213, United States; Recruiting
Pfizer Investigational Site, Pittsburgh, Pennsylvania, 15218, United States; Recruiting
Pfizer Investigational Site, Pittsburgh, Pennsylvania, 15224, United States; No longer recruiting
Pfizer Investigational Site, Philadelphia, Pennsylvania, 19115, United States; Recruiting
Pfizer Investigational Site, Altoona, Pennsylvania, 16601, United States; Recruiting
Pfizer Investigational Site, Altoona, Pennsylvania, 16602, United States; Recruiting
Pfizer Investigational Site, Mechanicsburg, Pennsylvania, 17055, United States; Recruiting
Pfizer Investigational Site, Philadelphia, Pennsylvania, 19146, United States; Recruiting
South Carolina
Pfizer Investigational Site, Anderson, South Carolina, 29621, United States; Recruiting
Pfizer Investigational Site, Greer, South Carolina, 29651, United States; Recruiting
Pfizer Investigational Site, Charleston, South Carolina, 29406, United States; Recruiting
Tennessee
Pfizer Investigational Site, Memphis, Tennessee, 38119, United States; Recruiting
Pfizer Investigational Site, Memphis, Tennessee, 38104, United States; Recruiting
Pfizer Investigational Site, Nashville, Tennessee, 37203, United States; Recruiting
Texas
Pfizer Investigational Site, San Antonio, Texas, 78229-3900, United States; Recruiting
Pfizer Investigational Site, Austin, Texas, 78705, United States; Recruiting
Pfizer Investigational Site, Lubbock, Texas, 79424, United States; Recruiting
Pfizer Investigational Site, San Antonio, Texas, 78229, United States; No longer recruiting
Pfizer Investigational Site, Dallas, Texas, 75246, United States; Recruiting
Pfizer Investigational Site, Richardson, Texas, 75080, United States; Recruiting
Utah
Pfizer Investigational Site, Salt Lake City, Utah, 84102, United States; Recruiting
Vermont
Pfizer Investigational Site, Woodstock, Vermont, 05091, United States; Recruiting
Virginia
Pfizer Investigational Site, Virginia Beach, Virginia, 23454, United States; Recruiting
Washington
Pfizer Investigational Site, Seattle, Washington, 98104, United States; Recruiting
Pfizer Investigational Site, Seattle, Washington, 98122, United States; Recruiting
Pfizer Investigational Site, Yakima, Washington, 98902, United States; Recruiting
Pfizer CT.gov Call Center, Study Director, Pfizer
More Information
Last Updated: September 8, 2005
Record first received: September 7, 2005
ClinicalTrials.gov Identifier: NCT00151528
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-09-13
Resources
- (National Women's Health Information Center, OWH, HHS)
- A Physician's Guide to Fibromyalgia Syndrome (Missouri Arthritis Rehabilitation Research and Training Center)

Not Signed In -

